[Today's focus]
The total net turnover of Bili-Bili-SW (09626.HK) in the second quarter increased 8% to reach 5.3 billion yuan, and the adjusted net loss narrowed sharply
Bilibili-SW (09626.HK) announced financial results for the second quarter of 2023. In the second quarter of 2023, total net turnover reached RMB 5.3 billion, up 8% from the same period in 2022; gross profit was RMB 1.2 billion, up 66% from the same period in 2022; gross profit was 23.1%, compared to the same period in 2022; net loss was RMB 1.5 billion, down 23% from the same period in 2022; adjusted net loss was RMB 964.1 million, down 51% from the same period in 2022; average daily active users were 96.5 million, an increase of 15% over the same period in 2022.
Cat's Eye Entertainment Releases Financial Report for the First Half of 2023: Revenue and Profit Reached a Record High for the Same Period, and Professional Capabilities Remain Leading in the Industry
On August 17, 2023, Maoyan Entertainment (stock code: 01896.HK), a leading “technology+full entertainment” service provider, officially announced the 2023 interim results announcement. According to the announcement, as of June 30, 2023, Maoye Entertainment's total revenue for the first half of 2023 was 2.197 billion yuan, up 84.4% from the same period last year; net profit was 405 million yuan, up 166.8% from the same period last year; adjusted net profit for the period was 456 million yuan.
Yixin Group (02858.HK)'s medium-term profit increased by 115% to 266 million yuan, and the number of NEV financing transactions surged 236%
Yi Xin Group (02858.HK) announced that in the six months ending June 30, 2023, the company's total revenue increased 16% year-on-year from RMB 2,452 billion in the same period last year to RMB 2,844 billion. Both self-operated financing business and trading platform business have grown. New revenue from the company's core business (including revenue from the company's loan facilitation services, SaaS services, and new self-operated financial leasing transactions facilitated by the company during the reporting period) increased 8% year-on-year from RMB 1,690 billion in the same period last year to RMB 1,821 billion.In the reporting period, the company's profit increased 115% year-on-year from RMB 124 million in the same period last year to RMB 266 million. This was mainly due to increased gross profit and reduced sales and marketing expenses. In the reporting period, adjusted net profit was RMB 413 million, compared to RMB 330 million for the same period last year.The company's total number of financing transactions in the reporting period was 312,000, an increase of 17% year-on-year over the 266,000 in the same period last year. Total financing during the reporting period was RMB 30.4 billion, an increase of 21% over the same period last year of RMB 25 billion.The number of new car financing transactions by the company during the reporting period was 180,000, an increase of 55% over the 116,000 in the same period last year; while the amount of financing during the reporting period was RMB 18.1 billion, an increase of 66% over RMB 10.9 billion in the same period last year.
Yingzhou (03700.HK) is profitable: estimated medium-term net profit of about 180-200 million yuan
Yingzhou (03700.HK) announced that the company expects to record a net profit of about RMB 180-200 million for the six months ending June 30, 2023. Compared with the net loss of about RMB 110 million for the same period last year, it turned a loss into a profit.
China Mobile Gaming (00302.HK) Profit: The adjusted net profit for the first half of the year is expected to be no less than 65 million yuan, turning a loss into a profit year-on-year
China Mobile Gaming (00302.HK) announced that according to a preliminary assessment of the Group's unaudited comprehensive management accounts for the six months ended June 30, 2023 and the information currently available to the board of directors, the Group's adjusted net profit forecast for the first half of 2023 is not less than RMB 65 million, while the adjusted net loss for the six months ending June 30, 2022 is approximately RMB 15.7 million. This loss to profit was mainly due to market recovery from the COVID-19 pandemic, normalization of game license distribution in China, and investment in fair value returns.
Luye Pharmaceutical (02186.HK): RYKINDOOfficially entered commercial operations in the US market
Luye Pharmaceutical (02186.HK) announcement, RYKINDO? The Group's microsphere technology platform was independently developed and approved for marketing by the US Food and Drug Administration (“FDA”) in January 2023. It is used to treat adult patients with schizophrenia, and as a monotherapy or as adjuvant therapy with lithium salt or valproate for maintenance treatment of adults with bipolar disorder type I
[Financial Data]
Kingdee International (00268.HK) revenue increased 16.8% in the first half of the year to 2,566 billion yuan
Bank of China Airlines Leasing (02588.HK) Interim Net Profit After Tax of US$262 million Interim Interest of US$0.1131
Fuyao Glass (03606.HK) net profit increased 19.08% in the first half of the year to 2,836 billion yuan
Yeju Healthcare (06929.HK)'s net profit soared 213.3% to US$25.183 million in the first half of the year
China Software International (00354.HK) medium-term net profit of 351 million yuan decreased by 38.6% year-on-year
Keystone Capital (00804.HK)'s mid-term net profit of HK$300,000 decreased 80% year-on-year
Saisheng Pharmaceutical's (06600.HK) medium-term net profit increased by about 18.4% to 630 million yuan
Binhai Investment (02886.HK)'s revenue for the first half of the year increased 2% to HK$3.119 billion
Baifu Global (00327.HK) medium-term net profit fell 7.0% year on year to HK$650 million
Haohai Biotechnology (06826.HK)'s mid-term net profit of 205 million yuan increased by 188.94% year-on-year
The mid-term revenue of Jiuxing Holdings (01836.HK) decreased by 13.4% to US$716 million
Tianfu (06868.HK) medium-term net profit increased by 31.7% to $98.9 million, interim interest of HK$0.05
The total retail sales of Maoye International (00848.HK) stores in the first half of the year reached 7.882 billion yuan, and net profit of 96 million yuan increased 11.8% year-on-year
Baisheng Group (03368.HK) changed from loss to profit of 63.1 million yuan in the medium term
Xinbang Holdings (01571.HK)'s net profit for the first half of the year increased by 53.11% to $264 million, with an interim interest rate of HK10 cents
Miramar Hotel (00071.HK)'s mid-term net profit increased by 86.5% to HK$380 million
The net profit of Shouchuang Environment (03989.HK) fell 44.41% in the first half of the year to 150 million yuan, and 55 projects were operated and tested
Bank of Luzhou (01983.HK)'s revenue increased 3.73% in the first half of the year to 2,447 billion yuan, net profit of 675 million yuan
Net profit attributable to shareholders of Yip's Chemical Group (00408.HK) for the first half of the year reached HK$16.3 million, with an interim dividend of HK2 cents per share
Xinhualian Capital (00758.HK)'s medium-term net profit of HK$3,588 million decreased by 69.6% year-on-year
Jinli Lai Group (00533.HK) net profit for the first half of the year fell 5% to HK$78.688 million
Dalipu Holdings (01921.HK)'s net profit soared 82.49% in the first half of the year to 56.8 million yuan, and its strategy to expand overseas markets paid off
Goyang Technology (00818.HK)'s medium-term net profit of HK$316 million decreased by 55% year-on-year
Wynn Macau (01128.HK) turned a loss into a profit of HK$87.5 million in the medium term
[Performance Forecast]
Via Biotech (01873.HK): Expected revenue of about 1,138 billion yuan for the first half of the year to record net profit attributable to the company's equity shareholders
Hima Ophthalmology (03309.HK) is profitable: net profit is expected to increase by about 68%-102% year-on-year in the first half of the year
China Glass (03300.HK) expects to lose 130 million yuan to 150 million yuan in the first half of the year
Beijing Jingkelong (00814.HK) Profit Warning: Net loss attributable to shareholders of the parent company is expected to be 40 million to 50 million yuan in the medium term
Far East Holdings International (00036.HK): Expected to lose no less than HK$17 million in the first half of the year
Junzhi Group (01300.HK) Earnings Warning: Mid-term Profit Expected to Decrease by About 29.6% Year Over Year
Xianshi (00244.HK) Earnings Warning: Expected medium-term net loss of HK$15 million to HK$20 million
Carpenter Tan (00837.HK) is happy: Mid-term profit is expected to increase by about 65% to 70% year-on-year
Grain Mill (01837.HK) Profit: Mid-term net profit is expected to increase by more than 52.8% year-on-year
Xinghe Holdings (01891.HK) expects net profit to decrease by about 55%-65% year-on-year in the first half of the year
C&D Xinsheng (00731.HK) expects a net loss of HK$94 million to HK$114 million for the first half of the year
China Huarong (02799.HK) expects mid-term net loss to narrow by about 73% to 76% year-on-year
Tiancheng Holdings (02110.HK) Earnings Warning: Expected annual loss of approximately HK$85.5 million to HK$94.7 million
Fuhui International Group Holdings (01034.HK) expects a net loss of about HK$40 million in the first half of the year
Wanma Holdings (06928.HK) expects to record a net loss increase of about SGD 2 million in the first half of the year
Lion Rock Group (01127.HK) expects mid-term net profit to drop 45% to 55%
Tongguan Gold (00340.HK) profit warning: net profit is expected to decrease by about 47% in the medium term
[Operational data]
Sunshine Insurance (06963.HK) The total premium income from the original insurance contract in January-July was about 76.699 billion yuan
Yida China (03639.HK) January-July contract sales amount is about 992 million yuan
[Resumption of trading and suspension of trading]
Changman Holdings (08523.HK): All conditions for resumption of trading have been met and trading will resume tomorrow
[Investment and operation]
Shiyao Group (01093.HK): NBL-028 was approved for clinical trials in the US for the treatment of tumors with advanced CLDN6 expression
Yuanda Pharmaceutical (00512.HK): APAD, a new drug to treat sepsis, completed the first patient enrolled in a phase I clinical study in China
Beijing Financial International (01468.HK) and Lasonic sign a memorandum of understanding to strengthen cooperation between the two sides in the field of IP
Sinopec Oil Service (01033.HK) won the bid for the EPC project worth about 1.53 billion yuan
Binhai Investment (02886.HK): Tianjin Junliangcheng Natural Gas Supply Project Officially Ventilated
[Repurchase Cancellation]
Standard Chartered Group (02888.HK) spent £12.77 million to repurchase 1,747 million shares on August 16
Yum China (09987.HK) spent 5.5 million US dollars to buy back 102,400 shares on August 16
Yuanzheng Technology (02488.HK) spent HK$1,678,800 to repurchase 641,500 shares on August 17
On August 17, Pudat Technology (00650.HK) spent HK$2,461,300 to repurchase 4.876 million shares
Changshi Group (01113.HK) spent HK$2.117 million to repurchase 500,000 shares on August 17
Tianli International Holdings (01773.HK) spent HK$1,308,000 to repurchase 500,000 shares on August 17
Xing Sheng Creation (00896.HK) spent HK$1.1 million to repurchase 1 million shares on August 17
[Equity Incentives]
Tencent Holdings (00700.HK) granted approximately 13.5619 million share options
Tencent Holdings (00700.HK) granted approximately 44384,900 bonus shares
Venture Group Holdings (02221.HK) granted 135.5 million share options
Haifeng International (01308.HK) awarded 21.4874 million bonus shares
[Debt financing]
China Ship Leasing (03877.HK) received loans of up to 750 million yuan from banks